Induction of heart valve lesions by small-molecule ALK5 inhibitors. (Q51423313)

5 April 2018

title

Induction of heart valve lesions by small-molecule ALK5 inhibitors. (English)

1 reference

5 April 2018

author name string

Mark J Anderton

1

1 reference

5 April 2018

Howard R Mellor

2

1 reference

5 April 2018

Alex Bell

3

1 reference

5 April 2018

Claire Sadler

4

1 reference

5 April 2018

Martin Pass

5

1 reference

5 April 2018

Steve Powell

6

1 reference

5 April 2018

Samantha J Steele

7

1 reference

5 April 2018

Ruth R A Roberts

8

1 reference

5 April 2018

Annabelle Heier

9

1 reference

5 April 2018

language of work or name

English

0 references

publication date

22 August 2011

1 reference

5 April 2018

published in

Toxicologic Pathology

1 reference

5 April 2018

volume

39

1 reference

5 April 2018

page(s)

916-924

1 reference

5 April 2018

issue

6

1 reference

5 April 2018

Transforming growth factor-beta signal transduction in angiogenesis and vascular disorders

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0192623311416259

Tumour microenvironment: TGFbeta: the molecular Jekyll and Hyde of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623311416259

Valvular heart disease associated with fenfluramine-phentermine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623311416259

Inhibition of ALK5 as a new approach to treat liver fibrotic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623311416259

Cardiac valvular pathology: comparative pathology and animal models of acquired cardiac valvular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623311416259

Drug-induced valvulopathy: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623311416259

5-hydroxytryptamine (5HT)-induced valvulopathy: compositional valvular alterations are associated with 5HT2B receptor and 5HT transporter transcript changes in Sprague-Dawley rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623311416259

A small molecule-kinase interaction map for clinical kinase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623311416259

Inhibition of ALK5 signaling induces physeal dysplasia in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623311416259

TGF-beta, Smad3 and the process of progressive fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623311416259

Alk3/Bmpr1a receptor is required for development of the atrioventricular canal into valves and annulus fibrosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623311416259

Rapid generation of a high quality lead for transforming growth factor-beta (TGF-beta) type I receptor (ALK5)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623311416259

Role of transforming growth factor-beta superfamily signaling pathways in human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623311416259

TGF-beta signaling in vascular biology and dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623311416259

Inhibition of gene markers of fibrosis with a novel inhibitor of transforming growth factor-beta type I receptor kinase in puromycin-induced nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623311416259

Gene expression profiling demonstrates that TGF-beta1 signals exclusively through receptor complexes involving Alk5 and identifies targets of TGF-beta signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623311416259

TGF-beta inhibitors for the treatment of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623311416259

Activin receptor-like kinase 2 can mediate atrioventricular cushion transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623311416259

ALK5 inhibition in renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623311416259

Abnormal angiogenesis but intact hematopoietic potential in TGF-beta type I receptor-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623311416259

Towards an anti-fibrotic therapy for scleroderma: targeting myofibroblast differentiation and recruitment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623311416259

Optimization of a dihydropyrrolopyrazole series of transforming growth factor-beta type I receptor kinase domain inhibitors: discovery of an orally bioavailable transforming growth factor-beta receptor type I inhibitor as antitumor agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623311416259

Transforming growth factor-beta regulates in vitro heart valve repair by activated valve interstitial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623311416259

TGFbeta-stimulated Smad1/5 phosphorylation requires the ALK5 L45 loop and mediates the pro-migratory TGFbeta switch

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623311416259

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623311416259

Endoglin and Alk5 regulate epithelial-mesenchymal transformation during cardiac valve formation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623311416259

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623311416259

TGF-beta signaling: a tale of two responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623311416259

Physiological actions and clinical applications of transforming growth factor-beta (TGF-beta).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623311416259

Dopamine agonists and the risk of cardiac-valve regurgitation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623311416259

Evolving concepts of cardiac valve dynamics: the continuum of development, functional structure, pathobiology, and tissue engineering

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623311416259

Nonoverlapping expression patterns of ALK1 and ALK5 reveal distinct roles of each receptor in vascular development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623311416259

Expression of a truncated, kinase-defective TGF-beta type II receptor in mouse skeletal tissue promotes terminal chondrocyte differentiation and osteoarthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623311416259

Mechanisms of TGF-beta signaling from cell membrane to the nucleus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623311416259

Dominant-negative ALK2 allele associates with congenital heart defects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623311416259

Essential functions of Alk3 during AV cushion morphogenesis in mouse embryonic hearts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623311416259

Signaling via the Tgf-beta type I receptor Alk5 in heart development

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623311416259

A novel small-molecule inhibitor of transforming growth factor beta type I receptor kinase (SM16) inhibits murine mesothelioma tumor growth in vivo and prevents tumor recurrence after surgical resection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623311416259

Regulation of cell proliferation by Smad proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623311416259

SD-208, a novel transforming growth factor beta receptor I kinase inhibitor, inhibits growth and invasiveness and enhances immunogenicity of murine and human glioma cells in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623311416259

Transforming growth factor-beta signaling through the Smad pathway: role in extracellular matrix gene expression and regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623311416259

Valvular myofibroblast activation by transforming growth factor-beta: implications for pathological extracellular matrix remodeling in heart valve disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623311416259

Atrioventricular cushion transformation is mediated by ALK2 in the developing mouse heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623311416259

Valvular heart disease and the use of dopamine agonists for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623311416259

21 January 2018

Identifiers

DOI

10.1177/0192623311416259

1 reference

5 April 2018

PubMed ID

21859884

1 reference

5 April 2018